Sec. 206. Cap on prescription drug cost-sharing
269 words·~1 min read·
/bill/115/hr/1776/ih/section-206A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 1302(c) of the Patient Protection and Affordable Care Act ( 42 U.S.C. 18022(c) ) is amended— in paragraph (3)(A)(i), by inserting (including cost-sharing with respect to prescription drugs covered by the plan) after copayments ; and by adding at the end the following: For plan years beginning in 2019 or later, the cost-sharing incurred under a health plan with respect to prescription drugs covered by the plan shall not exceed $250 per month for each enrolled individual, or $500 for each family. In the case of any plan year beginning in a calendar year after 2019, the limitation under this paragraph shall be equal to the applicable dollar amount under subparagraph
(A)for plan years beginning in 2019, increased by an amount equal to the product of that amount and the medical care component of the consumer price index for all urban consumers (as published by the Bureau of Labor Statistics) for that year. If the amount of any increase under clause
(i)is not a multiple of $5, such increase shall be rounded to the next lowest multiple of $5. . Section 2707(b) of the Public Health Service Act ( 42 U.S.C. 300gg–6(b) ) is amended by striking paragraph
(1)of section 1302(c) and inserting paragraphs
(1)and
(5)of section 1302(c) of the Patient Protection and Affordable Care Act . The amendments made by subsections
(a)and
(b)shall take effect with respect to the first plan year that begins after the date on which initial reports are required to be submitted under section 399V–7(c)(3) of the Public Health Service Act, as added by section 101.
Connectionstraces to 1
Traces to 1 document
1 reference not yet in our index
- 42 USC 300gg–6(b)
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources